Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosisParis, December 24, 2025.

Relapsing polychondritis is a rare disease that causes inflammation of your cartilage. It most commonly affects your ears, joints, and nose. Share on Pinterest Anatolijs Jascuks / EyeEm/Getty Images ...

Symptoms and frequency of relapses vary widely from person to person with the most common form of multiple sclerosis — and doctors aren’t entirely sure why. But, what exactly does a relapse look like?

As she prepares to change medications for her MS, columnist Leigh Anne Nelson explores the U.S. government’s registry on ...

The National Institute for Health and Care Excellence (NICE) has recommended ublituximab (Briumvi) for treating people with relapsing remitting multiple sclerosis (MS). The drug should be available ...

The neurological disease affects approximately 2.8 million people worldwide The neurological disease affects approximately 2.8 million people worldwide Sanofi has reported positive new data from a mid ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Recurring fever?

Most people with multiple sclerosis (MS) have a type called relapsing-remitting MS (RRMS). It usually starts in your 20s or 30s. If you have RRMS, you may have attacks when your symptoms flare up.

MS is due to the body’s defence system, or immune system, attacking the insulating cover of myelin that protects the nerves. This damages the nerves and impairs their ability to pass on electric ...